Literature DB >> 8086149

Could infected drug-users be potential Leishmania infantum reservoirs?

J Alvar, M Jiménez.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8086149     DOI： 10.1097/00002030-199406000-00024

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

Review 1.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients.

Authors:  R López-Vélez; F Laguna; J Alvar; J A Pérez-Molina; R Molina; P Martinez; J Villarrubia
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

3.  Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients.

Authors:  C Amela; D López-Gay; J C Alberdi; J Castilla
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

4.  Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

Authors:  J A Pineda; J A Gallardo; J Macías; J Delgado; C Regordán; F Morillas; F Relimpio; J Martín-Sánchez; A Sánchez-Quijano; M Leal; E Lissen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context.

Authors:  Ricardo Molina; Maribel Jiménez; Jesús García-Martínez; Juan Víctor San Martín; Eugenia Carrillo; Carmen Sánchez; Javier Moreno; Fabiana Alves; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2020-04-23

Review 6.  Spread of vector-borne diseases and neglect of Leishmaniasis, Europe.

Authors:  Jean-Claude Dujardin; Lenea Campino; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Ketty Soteriadou; Apostolos Mazeris; Yusuf Ozbel; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.